Garde Capital, Inc. A Tyr Pharma Inc Transaction History
Garde Capital, Inc.
- $1.87 Billion
- Q2 2025
A detailed history of Garde Capital, Inc. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Garde Capital, Inc. holds 200 shares of LIFE stock, worth $372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$372% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LIFE
# of Institutions
98Shares Held
50.1MCall Options Held
205KPut Options Held
306K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$7.45 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.55MShares$6.61 Million2.2% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.84MShares$5.29 Million0.01% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.68% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...